SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-19-000036
Filing Date
2019-11-12
Accepted
2019-11-12 08:56:20
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myovant10q9302019.htm   iXBRL 10-Q 1642219
2 EXHIBIT 10.1 myovantex1019302019.htm EX-10.1 18763
3 EXHIBIT 10.2 myovantex1029302019.htm EX-10.2 67944
4 EXHIBIT 31.1 myovantex3119302019.htm EX-31.1 10191
5 EXHIBIT 31.2 myovantex3129302019.htm EX-31.2 10310
6 EXHIBIT 32.1 myovantex3219302019.htm EX-32.1 6626
7 EXHIBIT 32.2 myovantex3229302019.htm EX-32.2 6287
  Complete submission text file 0001679082-19-000036.txt   6455015

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20190930.xsd EX-101.SCH 46011
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20190930_cal.xml EX-101.CAL 67767
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20190930_def.xml EX-101.DEF 249093
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20190930_lab.xml EX-101.LAB 596627
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20190930_pre.xml EX-101.PRE 360265
15 EXTRACTED XBRL INSTANCE DOCUMENT myovant10q9302019_htm.xml XML 849152
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 191206440
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences